Soutenir la recherche

Publications et ressources

Trier par :
Afficher :
21-30 sur 68

Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.

M Ziol, N Pote, Giuliana AMADDEO, A Laurent, JC Nault, F Oberti, C Costentin, S Michalak, M Bouattour, C Francoz, GP Pageaux, J Ramos, T Decaens, Alain LUCIANI, B Guiu, V Vilgrain, C Aubé, J Derman, C Charpy, J Zucman-Rossi, N Barget, O Seror, N Ganne-Carrie, V Paradis, Julien CALDERARO,

Hepatology 01/07/2018;68(1) : 103-112 10.1002/hep.29762. 09/05/2018

Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?

M Roux, F Pigneur, L Baranes, Julien CALDERARO, M Chiaradia, T Decaens, S Kastahian, A Charles-Nelson, L Tselikas, CE Costentin, A Laurent, D Azoulay, A Mallat, A Rahmouni, Alain LUCIANI,

Abdom Radiol (NY). 01/07/2018;43(7) : 1670-1681 10.1007/s00261-017-1377-z

Polycystic kidney features of the renal pathology in glycogen storage disease type I: possible evolution to renal neoplasia.

M Gjorgjieva, L Monteillet, Julien CALDERARO, G Mithieux, F Rajas,

J Inherit Metab Dis. 04/06/2018;- : - 10.1007/s10545-018-0207-y.

Hepatic Iron Overload following Liver Transplantation from a C282Y/H63D Compound Heterozygous Donor.

E Veitsman, E Pras, O Pappo, A Arish, R Eshkenazi, Cyrille FERAY, Julien CALDERARO, D Azoulay, ZB Ari,

Case Report Hepatol. 31/05/2018;2018 : 4298649 10.1155/2018/4298649

AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.

S Abitbol, R Dahmani, C Coulouarn, B Ragazzon, B Mlecnik, N Senni, M Savall, P Bossard, P Sohier, V Drouet, E Tournier, F Dumont, R Sanson, Julien CALDERARO, J Zucman-Rossi, M Vasseur-Cognet, PA Just, B Terris, C Perret, H Gilgenkrantz,

J Hepatol. 16/04/2018;68(6) : 1203-1213 10.1016/j.jhep.2017.12.018 16/04/2018

Hepatitis B virus pregenomic RNA in hepatocellular carcinoma: A nosological and prognostic determinant

B Halgand, C Desterke, L Riviere, G Fallot, M Sebagh, Julien CALDERARO, P Bioulac-Sage, C Neuveut, MA Buendia, D Samuel, Cyrille FERAY,

Hepatology. 01/01/2018;67(1) : 86-96 10.1002/hep.29463

Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention-to-treat analysis

RJ de Haas, C Lim, P Bhangui, C Salloum, P Compagnon, Cyrille FERAY, Julien CALDERARO, Alain LUCIANI, D Azoulay,

Hepatology. 01/01/2018;67(1) : 204-215 10.1002/hep.29468 15/11/2017

Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis

CE Costentin, T Decaens, A Laurent, JC Nault, B Paule, C Letoublon, Alain LUCIANI, Julien CALDERARO, R Adam, I Bricault, Giuliana AMADDEO, D Cherqui, A Mallat, D Samuel, C Duvoux, N Ganne-Carrie, F Roudot-Thoraval, E Vibert,

Liver Int. 01/12/2017;37(12) : 1869-1876 10.1111/liv.13491 13/07/2017

A phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of nononcogenic receptor tyrosine kinases

Y Fan, M Arechederra, S Richelme, F Daian, C Novello, Julien CALDERARO, L Di Tommaso, G Morcrette, S Rebouissou, M Donadon, E Morenghi, J Zucman-Rossi, M Roncalli, R Dono, F Maina,

Hepatology 01/11/2017;66(5) : 1644-1661 10.1002/hep.29304 29/09/2017

Afficher :
21-30 sur 68